LD-2 disclosure · 1st Quarter - Report (No Activity)
NEPHRON PHARMACEUTICALS CORPORATION
via THE VOGEL GROUP
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Developer and manufacturer of sterile inhalation and 503B outsourcing medication.
- Location
- South Carolina · United States of America
Registrant
- Firm
- THE VOGEL GROUP
- Description
- Global lobbying and business advisory firm
- Location
- Washington, District of Columbia, United States of America